Teladoc Health Inc (NYSE:TDOC) shares are rising in Wednesday’s after-hours session after the company reported better-than-expected results for the third quarter.
- Teladoc Health stock is charging ahead with explosive momentum. Why is TDOC stock up today?
Teladoc Q3 Earnings Highlights
Teladoc reported third-quarter revenue of $605.10 million, beating analyst estimates of $588.48 million. The telehealth company reported a third-quarter loss of 15 cents per share, beating estimates for a loss of 21 cents per share, according to Benzinga Pro.
Total revenue was down 3% on a year-over-year basis. U.S. revenue fell 4% year-over-year, while International revenue decreased 1% year-over-year. Here’s a breakdown of revenue by segment.
- Access Fees: down 10% to $466.7 million
- Integrated Care: up 2% to $398.5 million
- BetterHelp: down 13% to $206.6 million
“We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments,” said Chuck Divita, CEO of Teladoc Health.
Cash flow from operations was $106.5 million in the quarter and free cash flow came in at $75.9 million. The company said capital expenditures and capitalized software development costs totaled $30.5 million. Teladoc ended the period with approximately $849.91 million in cash and cash equivalents.
Teladoc expects fourth-quarter revenue of $569 million to $615 million versus estimates of $597.39 million. The company anticipates a fourth-quarter loss of three cents to 23 cents per share versus estimates for a loss of 11 cents per share.
Teladoc narrowed its full-year 2026 revenue guidance to a range of $2.395 billion to $2.441 billion versus estimates of $2.41 billion. The company improved its full-year earnings outlook to a loss in the range of 75 cents to 95 cents per share versus estimates of 89 cents per share.
TDOC Shares Move Higher After Earnings
TDOC Price Action: Teladoc shares were up 9.16% in after-hours, trading at $7.51 at the time of publication on Wednesday, according to Benzinga Pro.
Image: courtesy of Teladoc.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
